Epigenetic editing: a tunable CRISPR alternative
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Epic Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Epic Bio aims to transform genetic medicine by developing a new class of drugs that target the epigenome to alter gene expression.
Orthopedics Today | Innovation is required in areas of unmet clinical need, and this can be no truer than in the symptomatic post-meniscectomized knee.While many patients have improvements after meniscectomy, resection can alter joint biomechanics and overload articular cartilage. Long-term, 50% of meniscectomized patients develop symptomatic osteoarthritis due to increased contact pressures, which then leads to